World-first NO metabolite
The first metabolite-based approach to nitric oxide, raising NO without the conventional enzymatic pathways.
Dr. Chun Hyun Soo has spent more than two decades developing a fermentation-derived metabolite that raises nitric oxide directly, without depending on the NOS or nitrate-nitrite pathways.
My research did not start in a laboratory. It started with my mother, who was living with severe diabetes and hypertension that conventional medicine could not hold back.
I crafted a fermented blend of food ingredients already known to help regulate blood glucose and pressure, using fermentation to deepen their potency. Her recovery was dramatic, and it pointed to one answer: nitric oxide, produced without the NOS or nitrate-nitrite pathways the body normally relies on.
That single insight became twenty years of refinement.
Severe diabetes and hypertension, unmoved by conventional treatment, set the question that would define a career.
Foods known to regulate glucose and pressure, made markedly more potent through fermentation.
Her recovery revealed NO as the key, delivered directly and free of NOS and nitrate-nitrite dependence.
Isolating, stabilizing and standardizing the metabolite across more than 20 years of study.
Partnerships extending the metabolite toward applications in both foods and medicine.
Twenty years of research distilled into world-first technology, defensible patents, and published science.
The first metabolite-based approach to nitric oxide, raising NO without the conventional enzymatic pathways.
Patents covering the stabilization of nitric oxide metabolites through controlled fermentation.
Published findings on fermented extracts for inflammation and vascular health.
"Through my research, I aim to deliver a natural, potent nitric oxide metabolite for foods and medicines, extending healthspans worldwide."
Dr. Chun Hyun Soo